基于文獻分析中醫(yī)藥治療嶺南地區(qū)支氣管哮喘用藥規(guī)律

打開文本圖片集
[關鍵詞]支氣管哮喘;嶺南地區(qū);用藥規(guī)律;關聯(lián)規(guī)則分析;聚類分析
[中圖分類號]R256.12 [文獻標志碼]A [文章編號]0256-7415(2025)09-0006-06
DOI:10.13457/j.cnki.jncm.2025.09.002
Medication Rules of Chinese Medicine in Treating Bronchial Asthma in Lingnan Region Based on Literature Analysis
ZHANGTing1,CHENYiwei1,LIUYu2
1.TheFourthClinicalMedicalScholofGuangzhouUniversityofChineseMedicine,ShenzhenGuangdong518033,China;2.Shenzhen Traditional Chinese Medicine Hospital,Shenzhen Guangdong 518O33,China
Abstract:Objective:To explore the medication rulesand formulation characteristics of Chinese medicine in the treatmentof bronchial asthmainthe Lingnanregion based on literature analysis.Methods:Literatureon Chinese medicine treatmentof bronchialasthma in the Lingnanregionfrom January2OOOto March 2O24 wasretrieved from CNKI,VIP,Wanfang,Chinese Medical Journal Full-text Database,and SinoMed.A database of the selected prescriptions and herbs was established.Data mining techniques were used to perform frequency analysis,analysis of natures,flavors,channel entry and eficacy,association rules analysis,and cluster analysison the medicines. Results:A totalof 58 eligiblearticles were included,involving 71 prescriptionsand118 types of Chinese medicines. The natures of the medicines were mainlycold,warm,and neutral,with biter,acrid,and sweet flavors being predominant;the medicines primarily targeted the lung,spleen,stomach,heart,and kidney meridians.K-means cluster analysis identified four clusters of prescriptions.Conclusion:Chinese medicine treatment of bronchial asthma inthe Lingnan region emphasizes clearing lung and disolving phlegm,relieving cough and panting,and fortifying the spleenand boosting the kidney.It also considers theuseof exterior-releasingand heat-clearing medicines,often combined with herbs that dispel dampness and strengthen the spleen,utilizing locally sourced Lingnan medicinal materials.This provides an efectivereference for Chinese medicine treatmentofbronchial asthma inthe Lingnanregion.
Keywords:Bronchial asthma;Lingnan region;Medication rules;Association rules analysis;Cluster analysis
支氣管哮喘是由多種細胞及細胞組分參與的氣道慢性炎癥性疾病,可導致氣道高反應性和氣道重構,主要表現(xiàn)為反復發(fā)作的喘息、氣促、胸悶或咳嗽等癥狀2。(剩余6492字)